National immunization program: vaccination, compliance and pharmacovigilance

National immunization program: vaccination, compliance and pharmacovigilance

Bibliographic Details
Main Authors:	Carla Magda Allan S. Domingues, Antonia Maria da Silva Teixeira, Sandra Maria Deotti Carvalho
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2012-10-01
Series:	Revista do Instituto de Medicina Tropical de São Paulo
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652012000700009&lng=en&tlng=en

Similar Items

Pharmacovigilance in the vaccination program against coronavirus disease 19
by: Octavio Amancio-Chassin
Published: (2021-07-01)

Examining Socioeconomic and Computational Aspects of Vaccine Pharmacovigilance
by: Vasiliki Soldatou, et al.
Published: (2019-01-01)

Influenza tetravalent vaccines in national immunization programs for Latin-American countries
by: Macías Hernández, Alejandro E., et al.
Published: (2021)

Pharmacovigilance strategy: opportunities for cross-national learning
by: Irene Fermont
Published: (2019-06-01)

Annual meeting of representatives of National Pharmacovigilance Centers
by: R. N. Alyautdin
Published: (2018-02-01)

Pharmacovigilance
Published: (2019)

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences
by: H. Hilda Ampadu, et al.
Published: (2018-11-01)

Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
by: Caterina Palleria, et al.
Published: (2018-01-01)

Pharmacovigilance Volume 2
Published: (2023)

Hib vaccine: Should it be introduced in the national immunization program?
by: Davendra K Taneja
Published: (2012-01-01)

Pharmacovigilance in India
by: Sarita Mulkalwar, et al.
Published: (2013-01-01)

ON THE SUBJECT OF PHARMACOVIGILANCE
by: M. A. Murashko
Published: (2015-09-01)

ON THE SUBJECT OF PHARMACOVIGILANCE
by: M. A. Murashko
Published: (2015-09-01)

Pharmacovigilance and Moroccan Tuberculosis Public Program: Current Situation
by: Driss Soussi Tanani, et al.
Published: (2014-01-01)

Risk minimization measures in pharmacovigilance: review of national and international experience
by: V. A. Komissarova
Published: (2020-01-01)

PARTICULARITIES OF PHARMACOVIGILENCE ACTIVITY IN DENTISTRY
by: Ioana Maria Hunea, et al.
Published: (2019-04-01)

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
by: Douglas B. Johnson, et al.
Published: (2019-05-01)

The Role of an Interventional Program for Improving Pharmacovigilance at a Pediatric Facility
by: Nirit Kronenfeld, et al.
Published: (2019-09-01)

Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment
by: Denise Naniche, et al.
Published: (2021-06-01)

The Role of Pharmacovigilance in the COVID-19 Pandemic
by: Renato Ferreira-da-Silva, et al.
Published: (2021-03-01)

DEBATABLE PROBLEMS OF PHARMACOVIGILANCE
by: Yu. V. Muravyev, et al.
Published: (2018-03-01)

Automated pharmacovigilance system
by: O. A. Loginovskaya, et al.
Published: (2018-05-01)

Pharmacovigilance programme of India
by: Kalaiselvan Vivekanandan, et al.
Published: (2012-01-01)

Pharmacovigilance Programme of India
by: Duvvuru Ashok Kumar, et al.
Published: (2015-01-01)

Generic drugs and pharmacovigilance
by: Nelson Santiago Vispo
Published: (2017-11-01)

Pharmacovigilance in clinical trials
by: Ilić Katarina, et al.
Published: (2007-01-01)

Pharmacovigilance: Curriculum and career
by: Bhaswat S Chakraborty
Published: (2014-01-01)

Patients centred pharmacovigilance
by: Scurti, Veronica
Published: (2011)

Elements of veterinary pharmacovigilance
by: Cristina, T. Romeo,, et al.
Published: (2009-12-01)

Literature Monitoring for Pharmacovigilance
by: A. G. Khudoshin, et al.
Published: (2019-03-01)

Terms recommended for pharmacovigilance
by: B. K. Romanov
Published: (2018-02-01)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
by: Cristina Scavone, et al.
Published: (2018-09-01)

Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey
by: Lisa Stagi, et al.
Published: (2021-02-01)

COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
by: N. I. Mikshis, et al.
Published: (2018-11-01)

Association between timely initiation of hepatitis B vaccine and completion of the hepatitis B vaccine and national immunization program vaccine series
by: Jiang-nan Wu, et al.
Published: (2016-10-01)

Challenges to the consolidation of pharmacovigilance practices in Brazil: limitations of the hospital pharmacist
by: Paulo Henrique Santos Andrade, et al.
Published: (2020-07-01)

Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program
by: Mikhail Tarasov, et al.
Published: (2020-08-01)

Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
by: Abimbola O. Opadeyi, et al.
Published: (2018-05-01)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2020-06-01)

Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal
by: Maria da Conceição Constantino Portela, et al.
Published: (2017-03-01)